The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.

An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, ...

The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA ...

Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Scientists have discovered a surprising new connection between gut health and blood cancer risk one that could transform how we think about aging, inflammation, and the early stages of leukemia.

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...